CoChat

Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistance

Open access
Costello, Harry, Roiser, Jonathan P., Howard, Robert · 2023 · Psychological Medicine

The DOI matches its Crossref record; 164 of the 165 references it cites were found in a registry or an index.

Abstract

Depression in dementia is common, disabling and causes significant distress to patients and carers. Despite widespread use of antidepressants for depression in dementia, there is no evidence of therapeutic efficacy, and their use is potentially harmful in this patient group. Depression in dementia has poor outcomes and effective treatments are urgently needed. Understanding why antidepressants are ineffective in depression in dementia could provide insight into their mechanism of action and aid identification of new therapeutic targets. In this review we discuss why depression in dementia may be a distinct entity, current theories of how antidepressants work and how these mechanisms of action may be affected by disease processes in dementia. We also consider why clinicians continue to prescribe antidepressants in dementia, and novel approaches to understand and identify effective treatments for patients living with depression and dementia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s003329172200397x

Cites

164 of 164 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Reproduced forest plot of meta-analysis of included Cochrane review randomised controlled trials of antidepressants for depression in dementia. (Dudas et al. 2018) (AD - Alzheimer's dementia, VD - Vascular dementia, M - mixed dementia, PDD - Parkinson's disease dementia, SSRI - selective serotonin reuptake inhibitor, TCA - tricyclic antidepressant, SNRI - serotonin-noradrenaline reuptake inhibitor, NASSA - noradrenaline and specific serotonergic antidepressant).
Fig. 1. Reproduced forest plot of meta-analysis of included Cochrane review randomised controlled trials of antidepressants for depression in dementia. (Dudas et al. 2018) (AD - Alzheimer's dementia, VD - Vascular dementia, M - mixed dementia, PDD - Parkinson's disease dementia, SSRI - selective serotonin reuptake inhibitor, TCA - tricyclic antidepressant, SNRI - serotonin-noradrenaline reuptake inhibitor, NASSA - noradrenaline and specific serotonergic antidepressant).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 164 references

Research works printed but not linked: 3

  1. 10.1176/jnp.17.2.214 · doi:10.1176/jnp.17.2.214 · Paper page
  2. 10.3109/hrp.7.1.1 · DOI
  3. 10.1176/jnp.13.1.5 · doi:10.1176/jnp.13.1.5 · Paper page

Cited by

See all 65

Metadata

Authors
Costello, H., Roiser, J. P., & Howard, R.
Affiliations
University College London (GB)
Corresponding author
Costello, Harry
Venue
Psychological Medicine
Published
2023-01-09
Volume
53
Issue
3
Pages
654-667
ISSN
  • 0033-2917 (ISSN-L)
  • 1469-8978
OpenAlex
W4313877462
Cited by
60
References
165
Citations by year
2026: 17 · 2025: 19 · 2024: 17 · 2023: 7
FWCI
2.18
Type
journal article
Language
en
Open access
Locations
  • Psychological Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion, cc-by)
Funders
Wellcome Trust (101798/Z/13/Z, 175479)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
depression in dementia, antidepressants, treatment resistance, antidepressant mechanism, antidepressant efficacy, antidepressant prescribing, dementia, novel therapeutic targets
MeSH terms
Antidepressive Agents, Dementia, Humans, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistance. https://app.cochat.ai/papers/10.1017/s003329172200397x
The paper
Costello, H., Roiser, J. P., & Howard, R. (2023). Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistance. Psychological Medicine. https://doi.org/10.1017/s003329172200397x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.